Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Kissimmee › NPI 1912246786
Hospital

Poinciana Medical Center, INC.

Poinciana Medical Center, INC. was paid $17.14M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 99283, emergency room visit (moderate) — 45% of everything it billed.

33Billing provider infoPOINCIANA MEDICAL CENTER, INC.
KISSIMMEE, FL 34758
33aNPI1912246786assigned 02/13/2013
33bProvider typeGeneral Acute Care Hospital
28Total paid$17.14M
24GClaims612,219
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#24 of 163
Median peer was paid$4.77M
This provider vs. median3.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201830,115$308K
2019126,338$1.73M
202086,923$1.33M
2021106,221$2.88M
2022110,776$4.16M
202390,761$4.07M
2024incomplete61,085$2.68M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 45% 81,714 73,668 $7.68M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 36,788 31,798 $2.74M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.7% 5,087 4,409 $809K
36415 Collection of venous blood by venipuncture 4.6% 41,296 35,192 $780K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.3% 9,266 8,591 $741K
70450 Computed tomography, head or brain; without contrast material 3.8% 5,588 4,853 $647K
80053 Comprehensive metabolic panel 2.5% 31,568 26,281 $431K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.3% 2,952 2,570 $388K
96361 Intravenous infusion, hydration; each additional hour 2.1% 3,769 3,313 $355K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.9% 5,497 4,580 $319K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.5% 2,636 2,465 $265K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.2% 4,167 3,971 $202K
135 more codes
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 22,759 $182K
87070 1.0% 9,469 $180K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 8,709 $125K
71045 Radiologic examination, chest; single view <1% 19,528 $122K
71275 Computed tomographic angiography, chest, with contrast material <1% 829 $109K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 10,334 $90K
72125 Computed tomography, cervical spine; without contrast material <1% 1,251 $81K
J7050 Infusion, normal saline solution, 250 cc <1% 1,191 $54K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,645 $50K
81001 <1% 11,531 $47K
71046 Radiologic examination, chest; 2 views <1% 2,776 $43K
74018 <1% 1,821 $35K
81003 <1% 15,180 $34K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 12,664 $30K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,683 $29K
73610 <1% 1,355 $27K
80048 Basic metabolic panel (calcium, ionized) <1% 3,239 $26K
73130 <1% 1,292 $26K
73562 <1% 1,438 $23K
81025 <1% 9,582 $22K
87802 <1% 5,619 $22K
73630 <1% 1,371 $20K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 589 $20K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 12,406 $19K
72131 <1% 607 $18K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,709 $17K
12011 <1% 189 $17K
12001 <1% 195 $17K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 505 $15K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,151 $15K
73030 <1% 1,047 $13K
76801 <1% 1,481 $13K
G0378 Hospital observation service, per hour <1% 3,183 $13K
73110 <1% 829 $13K
76830 Ultrasound, transvaginal <1% 885 $12K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 14,512 $12K
85027 <1% 37,157 $12K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,980 $11K
J7030 Infusion, normal saline solution , 1000 cc <1% 14,930 $10K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 665 $10K
72100 <1% 857 $10K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,859 $8K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 29 $8K
84484 <1% 7,470 $7K
87040 <1% 955 $7K
93971 <1% 437 $6K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 5,246 $5K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 120 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 531 $5K
87807 <1% 1,411 $5K
73080 <1% 256 $5K
96375 Therapeutic injection; each additional sequential IV push <1% 9,330 $5K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,656 $4K
A9270 Non-covered item or service <1% 3,736 $4K
83880 <1% 3,781 $4K
84703 <1% 6,869 $3K
84702 <1% 2,669 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 90 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,182 $3K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 396 $3K
10060 <1% 54 $3K
87430 <1% 1,846 $3K
83690 <1% 10,288 $3K
87210 <1% 830 $2K
86900 <1% 1,520 $2K
93017 <1% 162 $2K
73590 <1% 125 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,742 $2K
83735 <1% 7,173 $2K
85610 <1% 5,336 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,409 $2K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,197 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,412 $1K
85379 <1% 2,354 $1K
J1815 Injection, insulin, per 5 units <1% 1,011 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,630 $1K
80061 Lipid panel <1% 890 $1K
85730 <1% 3,052 $839.83
74021 <1% 48 $834.88
80047 <1% 609 $759.41
72040 <1% 113 $751.54
84443 Thyroid stimulating hormone (TSH) <1% 1,791 $745.80
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 4,593 $730.56
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,545 $690.19
90715 <1% 475 $633.94
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 1,553 $475.25
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 167 $463.66
J8540 Dexamethasone, oral, 0.25 mg <1% 1,907 $440.58
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,231 $348.04
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,867 $315.13
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,821 $260.98
84145 <1% 72 $161.82
82550 <1% 298 $154.68
85651 <1% 205 $114.78
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,189 $83.09
J2060 Injection, lorazepam, 2 mg <1% 818 $75.88
70486 <1% 14 $70.88
J0561 Injection, penicillin g benzathine, 100,000 units <1% 229 $67.30
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 105 $52.64
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 778 $32.59
86850 <1% 453 $16.66
96376 <1% 466 $14.51
86140 <1% 189 $13.05
87186 <1% 854 $10.67
83605 <1% 826 $8.00
80076 <1% 419 $6.74
86901 <1% 1,489 $5.44
J2300 Injection, nalbuphine hydrochloride, per 10 mg <1% 439 $4.91
87147 0% 190 $0.00
83036 Hemoglobin; glycosylated (A1C) 0% 80 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 446 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 156 $0.00
80320 0% 166 $0.00
83615 0% 32 $0.00
73090 0% 30 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 86 $0.00
80329 0% 36 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 28 $0.00
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 0% 14 $0.00
82553 0% 44 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 34 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 39 $0.00
82077 0% 15 $0.00
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 0% 12 $0.00
84100 0% 86 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 44 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 45 $0.00
J2800 Injection, methocarbamol, up to 10 ml 0% 75 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 208 $0.00
S0028 Injection, famotidine, 20 mg 0% 33 $0.00
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 55 $0.00
82800 0% 17 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 0% 85 $0.00
J0595 Injection, butorphanol tartrate, 1 mg 0% 61 $0.00
82009 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialESPINALES, NATHALIE (CFO)